Publications

• Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease.
  Blood Adv Volume: 9 Page(s): 955 - 965
  03/11/2025 Authors: Walters MC; Eapen M; Liu Y; El Rassi F; Waller EK; Levine JE; Strouse JJ; Antin JH; Parikh SH; Bakshi N
• High symptom burden in female X-linked chronic granulomatous disease carriers.
  Clin Immunol Volume: 268 Page(s): 110364
  11/01/2024 Authors: Miranda MA; Tsalatsanis A; Trotter JR; Arnold DE; Squire JD; Kidd S; Parikh S; Marsh RA; Griffith LM; Mallhi K
• HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum.
  J Clin Immunol Volume: 44 Page(s): 153
  06/19/2024 Authors: Golloshi K; Mitchell W; Kumar D; Malik S; Parikh S; Aljudi AA; Castellino SM; Chandrakasan S
• Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: APrimary Immune Deficiency Treatment Consortium study.
  J Allergy Clin Immunol Volume: 153 Page(s): 1423 - 1431.e2
  05/01/2024 Authors: Grunebaum E; Arnold DE; Logan B; Parikh S; Marsh RA; Griffith LM; Mallhi K; Chellapandian D; Lim SS; Deal CL
• Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
  Nat Commun Volume: 15 Page(s): 3258
  04/18/2024 Authors: Keller MD; Hanley PJ; Chi Y-Y; Aguayo-Hiraldo P; Dvorak CC; Verneris MR; Kohn DB; Pai S-Y; Dvila Saldaa BJ; Hanisch B
• Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication.
  Nat Commun Volume: 15 Page(s): 2749
  03/29/2024 Authors: Keller MD; Schattgen SA; Chandrakasan S; Allen EK; Jensen-Wachspress MA; Lazarski CA; Qayed M; Lang H; Hanley PJ; Tanna J
• D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
  Am J Hematol Volume: 99 Page(s): 370 - 379
  03/01/2024 Authors: Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B
• JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
  J Allergy Clin Immunol Volume: 153 Page(s): 275 - 286.e18
  01/01/2024 Authors: Fischer M; Olbrich P; Hadjadj J; Aumann V; Bakhtiar S; Barlogis V; von Bismarck P; Bloomfield M; Booth C; Buddingh EP
• Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
  Blood Volume: 142 Page(s): 2105 - 2118
  12/14/2023 Authors: Leiding JW; Arnold DE; Parikh S; Logan B; Marsh RA; Griffith LM; Wu R; Kidd S; Mallhi K; Chellapandian D
• Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.
  J Allergy Clin Immunol Volume: 152 Page(s): 1619 - 1633.e11
  12/01/2023 Authors: Chandrasekaran P; Han Y; Zerbe CS; Heller T; DeRavin SS; Kreuzberg SA; Marciano BE; Siu Y; Jones DR; Abraham RS
• Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
  Transplant Cell Ther Volume: 29 Page(s): 778.e1 - 778.e6
  12/01/2023 Authors: Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH
• Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature.
  Pediatr Blood Cancer Volume: 70 Page(s): e30606
  10/01/2023 Authors: Hughes C; Harris A; Watkins B; Qayed M; Parikh S; Horwitz E; Stenger E; Williams KM; Schoettler ML
• Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
  Lancet Volume: 402 Page(s): 129 - 140
  07/08/2023 Authors: Thakar MS; Logan BR; Puck JM; Dunn EA; Buckley RH; Cowan MJ; O'Reilly RJ; Kapoor N; Satter LF; Pai S-Y
• DARATUMUMAB FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA IN PEDIATRIC PATIENTS POST-HEMATOPOIETIC CELL TRANSPLANT
  Volume: 70 Page(s): S214 - S215
  06/01/2023 Authors: Yoo J; Obordo J; Schoettler M; Qayed M; Hughes K; Harris A; Spencer K; Parikh S; Chandrakasan S; Chonat S
• Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.
  Blood Adv Volume: 7 Page(s): 1784 - 1795
  05/09/2023 Authors: Schoettler M; Stenger E; Spencer K; Lutterman D; Rumbika S; Jones J; Haight A; Parikh S; Qayed M; Watkins B
• Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.
  Transplant Cell Ther Volume: 29 Page(s): 338.e1 - 338.e6
  05/01/2023 Authors: Lin C; Schwarzbach A; Sanz J; Montesinos P; Stiff P; Parikh S; Brunstein C; Cutler C; Lindemans CA; Hanna R
• BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
  J Immunother Cancer Volume: 11
  05/01/2023 Authors: Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• cDNA sequencing increases the molecular diagnostic yield in Chediak-Higashi syndrome.
  Front Genet Volume: 14 Page(s): 1072784
  01/01/2023 Authors: Kuptanon C; Morimoto M; Nicoli E-R; Stephen J; Yarnell DS; Dorward H; Owen W; Parikh S; Ozbek NY; Malbora B
• CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.
  Clin Lymphoma Myeloma Leuk Volume: 22 Suppl 2 Page(s): S442
  10/01/2022 Authors: Lin C; Schwarzbach A; Montesinos P; Stiff P; Cutler C; Parikh S; Brunstein C; Lindemans CA; Hanna R; Koh LP
• Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials
  Volume: 22 Page(s): S442 - S442
  10/01/2022 Authors: Lin C; Schwarzbach A; Montesinos P; Stiff P; Cutler C; Parikh S; Brunstein C; Lindemans CA; Hanna R; Koh LP
• Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy.
  J Clin Immunol Volume: 42 Page(s): 1026 - 1035
  07/01/2022 Authors: Arnold DE; Chellapandian D; Parikh S; Mallhi K; Marsh RA; Heimall JR; Grossman D; Chitty-Lopez M; Murguia-Favela L; Gennery AR
• HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh.
  Blood Adv Volume: 6 Page(s): 3751 - 3755
  06/28/2022 Authors: Chandrakasan S; Chandra S; Prince C; Kobrynski LJ; Lucas L; Patel K; Walter J; Buckley RH; Meisel R; Ghosh S
• BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA
  Volume: 69
  06/01/2022 Authors: Raghunandan S; Pauly M; Blum W; Qayed M; Dhodapkar M; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation.
  Blood Adv Volume: 6 Page(s): 3058 - 3061
  05/24/2022 Authors: Janardan S; Horwitz E; Watkins B; Williams K; Chandrakasan S; Qayed M; Parikh S; Arnold S; Keller F; Alazraki A
• Transplanted CGD Patients have Higher Burden of Disease than Conventionally Treated Patients that Resolve with Transplantation - A PIDTC Report
  Volume: 42 Page(s): S76 - S78
  04/01/2022 Authors: Leiding J; Danielle A; Parikh S; Logan B; Marsh R; Griffith L; Wu R; Mallhi K; Chellapandian D; Lim S
• Sirolimus treatment improves both cytopenia and underlying immune dysregulation in Evans syndrome
  Volume: 42 Page(s): S100 - S101
  04/01/2022 Authors: KUMAR DEEPAK; Nguyen TH; Bennett CM; Lucas L; Prince C; Parikh S; Park S; Prahalad S; Briones M; Chandrakasan S
• T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.
  Blood Volume: 139 Page(s): 369 - 383
  01/20/2022 Authors: Kumar D; Prince C; Bennett CM; Briones M; Lucas L; Russell A; Patel K; Chonat S; Graciaa S; Edington H
• Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy.
  J Clin Immunol Volume: 41 Page(s): 1597 - 1606
  10/01/2021 Authors: Baloh CH; Borkar SA; Chang K-F; Yao J; Hershfield MS; Parikh SH; Kohn DB; Goodenow MM; Sleasman JW; Yin L
• Hematopoietic Stem Cell Transplant Outcomes in Adolescent and Young Adults with Immune Disorders
  Volume: 41 Page(s): S31 - S31
  04/01/2021 Authors: Bauchat A; Lucas L; Leavenworth D; Parikh S; Chandrakasan S
• Allogeneic stem cell transplantation with omidubicel in sickle cell disease.
  Blood Adv Volume: 5 Page(s): 843 - 852
  02/09/2021 Authors: Parikh S; Brochstein JA; Galamidi E; Schwarzbach A; Kurtzberg J
• Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
  J Clin Immunol Volume: 40 Page(s): 1211 - 1213
  11/01/2020 Authors: Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E
• Use of Letermovir for Salvage Therapy for Resistant Cytomegalovirus in a Pediatric Hematopoietic Stem Cell Transplant Recipient.
  J Pediatric Infect Dis Soc Volume: 9 Page(s): 486 - 489
  09/17/2020 Authors: Kilgore JT; Becken B; Varga MG; Parikh S; Prasad V; Lugo D; Chang Y-C
• Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
  Blood Volume: 135 Page(s): 2094 - 2105
  06/04/2020 Authors: Burroughs LM; Petrovic A; Brazauskas R; Liu X; Griffith LM; Ochs HD; Bleesing JJ; Edwards S; Dvorak CC; Chaudhury S
• Third-Party Virus-Specific T-Cell Infusion for Treatment of Refractory Viral Infections: Interim Results from PBMTC SUP1701
  Volume: 26 Page(s): S89 - S90
  03/01/2020 Authors: Keller MD; Hanley PJ; Zhang N; Tanna J; Fatic A; Lang H; Ekanem U; Sani GM; Aguayo-Hiraldo PI; Quigg TC
• Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.
  Front Immunol Volume: 11 Page(s): 239
  01/01/2020 Authors: Chan AY; Leiding JW; Liu X; Logan BR; Burroughs LM; Allenspach EJ; Skoda-Smith S; Uzel G; Notarangelo LD; Slatter M
• Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency.
  Front Immunol Volume: 11 Page(s): 574738
  01/01/2020 Authors: Geier CB; Farmer JR; Foldvari Z; Ujhazi B; Steininger J; Sleasman JW; Parikh S; Dilley MA; Pai S-Y; Henderson L
• Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
  J Clin Immunol Volume: 39 Page(s): 653 - 667
  10/01/2019 Authors: Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E
• OUTCOMES OF SUBSEQUENT TRANSPLANT FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES WHO RELAPSE
  Volume: 66
  06/01/2019 Authors: Stafford L; Troy J; Driscoll T; Page K; Parikh S; Prasad V; Kurtzberg J; Martin P
• Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant.
  JAMA Pediatr Volume: 173 Page(s): e190081
  05/01/2019 Authors: Parikh SH; Satwani P; Ahn KW; Sahr NA; Fretham C; Abraham AA; Agrawal V; Auletta JJ; Abdel-Azim H; Copelan E
• Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.
  Am J Hematol Volume: 94 Page(s): 446 - 454
  04/01/2019 Authors: Krishnamurti L; Neuberg DS; Sullivan KM; Kamani NR; Abraham A; Campigotto F; Zhang W; Dahdoul T; De Castro L; Parikh S
• Ethical considerations of using a single minor donor for three bone marrow harvests for three HLA-matched siblings with primary immunodeficiency.
  Pediatr Blood Cancer Volume: 66 Page(s): e27602
  04/01/2019 Authors: Parikh SH; Pentz RD; Haight A; Adeli M; Martin PL; Driscoll TA; Page K; Kurtzberg J; Prasad VK; Barfield RC
• Reduction in Mortality after Umbilical Cord Blood Transplantation in Children Over a 20-Year Period (1995-2014).
  Biol Blood Marrow Transplant Volume: 25 Page(s): 756 - 763
  04/01/2019 Authors: Spees LP; Martin PL; Kurtzberg J; Stokhuyzen A; McGill L; Prasad VK; Driscoll TA; Parikh SH; Page KM; Vinesett R
• Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency.
  J Allergy Clin Immunol Pract Volume: 7 Page(s): 848 - 855
  03/01/2019 Authors: Aydin SE; Freeman AF; Al-Herz W; Al-Mousa HA; Arnaout RK; Aydin RC; Barlogis V; Belohradsky BH; Bonfim C; Bredius RG
• VASCULITIS AS A MAJOR MORBIDITY FACTOR IN PATIENTS WITH HYPOMORPHIC RAG VARIANTS
  Volume: 58 Page(s): 76 - 76
  03/01/2019 Authors: Calabrese L; Geier C; Farmer J; Foldvari Z; Ujhazi B; Eibl M; Wolf H; Sleasman J; Parikh S; Dilley M
• Outcomes of Umbilical Cord Blood Transplantation in Children with Batten Disease
  Volume: 25
  03/01/2019 Authors: Brondon JE; Page K; Polishchuk V; Driscoll TA; Parikh S; Martin PL; Kurtzberg J; Prasad VK
• HSCT Utilizing Related Carrier Donor for CD40 Ligand Deficiency
  Volume: 39 Page(s): S124 - S125
  02/01/2019 Authors: Chandrakasan S; Chandra S; Kobrynski L; Parikh SH
• Vasculitis as a major morbidity factor in patients with hypomorphic RAG mutations
  Volume: 143 Page(s): AB116 - AB116
  02/01/2019 Authors: Geier CB; Farmer JR; Foldvari Z; Ujhazi B; Eibl MM; Wolf HM; Sleasman JW; Parikh S; Dilley MA; Pai S-Y
• Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.
  J Allergy Clin Immunol Pract Volume: 7 Page(s): 1970 - 1985.e4
  01/01/2019 Authors: Farmer JR; Foldvari Z; Ujhazi B; De Ravin SS; Chen K; Bleesing JJH; Schuetz C; Al-Herz W; Abraham RS; Joshi AY
• Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies.
  J Allergy Clin Immunol Volume: 142 Page(s): 2004 - 2007
  12/01/2018 Authors: Marsh RA; Hebert KM; Keesler D; Boelens JJ; Dvorak CC; Eckrich MJ; Kapoor N; Parikh S; Eapen M
• Long-Term Functional Outcomes after Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease.
  Biol Blood Marrow Transplant Volume: 24 Page(s): 2233 - 2238
  11/01/2018 Authors: Allewelt H; Taskindoust M; Troy J; Page K; Wood S; Parikh S; Prasad VK; Kurtzberg J
• Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.
  Biol Blood Marrow Transplant Volume: 24 Page(s): 1216 - 1222
  06/01/2018 Authors: Shenoy S; Walters MC; Ngwube A; Soni S; Jacobsohn D; Chaudhury S; Grimley M; Chan K; Haight A; Kasow KA
• Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.
  J Pediatric Infect Dis Soc Volume: 7 Page(s): S31 - S39
  05/09/2018 Authors: Connelly JA; Marsh R; Parikh S; Talano J-A
• Hematopoietic stem cell transplantation in patients with primary immune regulatory disorders: a Primary Immune Deficiency Treatment Consortium (PIDTC) and Inborn Errors Working Party (IEWP) Study
  Volume: 38 Page(s): 367 - 367
  04/01/2018 Authors: Leiding JW; Chan A; Allenspach E; Uzel G; Notarangelo L; Gennery A; Slatter M; Smith AR; Pai S-Y; Marsh R
• Recent outcome of hematopoietic cell transplantation for Wiskott-Aldrich syndrome is excellent in all donor types: A Primary Immune Deficiency Treatment Consortium (PIDTC) Study
  Volume: 38 Page(s): 399 - 400
  04/01/2018 Authors: Pai S-Y; Brazauskas R; Bleesing J; Dvorak CC; Kletzel M; Petrovic A; Prockop SE; Quinones R; Goldman FD; Quigg TC
• Resolution of CGD Related Colitis after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Granulomatous Disease-Early Results From the 6903 Study of the Primary Immune Deficiency Treatment Consortium (PIDTC)
  Volume: 24 Page(s): S53 - S54
  03/01/2018 Authors: Leiding JW; Logan BR; Yin Z; Arbuckle E; Bleesing JJ; Sullivan KE; Heimall J; Burroughs L; Skoda-Smith S; Chandrakasan S
• A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD
  Volume: 24 Page(s): S157 - S158
  03/01/2018 Authors: Parikh S; Brochstein JA; Wease S; Martin PL; Horwitz ME; Schwarzbach A; Kurtzberg J
• Survival Trends after Allogeneic Hematopoietic Cell Transplant (HCT) in Children Less Than One-Year-Old (Infants)
  Volume: 24 Page(s): S97 - S98
  03/01/2018 Authors: Parikh S; Ahn KW; Sahr N; Zhu X; Abraham A; Auletta JJ; Chhabra S; Copelan EA; Dvorak CC; Fretham C
• Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.
  J Allergy Clin Immunol Volume: 141 Page(s): 322 - 328.e10
  01/01/2018 Authors: Slack J; Albert MH; Balashov D; Belohradsky BH; Bertaina A; Bleesing J; Booth C; Buechner J; Buckley RH; Ouache-Chardin M
• Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
  Blood Volume: 130 Page(s): 2718 - 2727
  12/21/2017 Authors: Heimall J; Logan BR; Cowan MJ; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Pulsipher MA; Parikh S; Martinez C
• A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for -Thalassemia.
  Biol Blood Marrow Transplant Volume: 23 Page(s): 1695 - 1700
  10/01/2017 Authors: Chaudhury S; Ayas M; Rosen C; Ma M; Viqaruddin M; Parikh S; Kharbanda S; Chiang KY; Haight A; Bhatia M
• Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
  Biol Blood Marrow Transplant Volume: 23 Page(s): 1722 - 1728
  10/01/2017 Authors: Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
• Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency patients cures combined immunodeficiency and prevents progression of neurological symptoms
  Volume: 147 Page(s): 43S - 43S
  05/29/2017 Authors: Herrmann US; Ehlert C; Strahm B; Niemeyer C; Worth A; Gennery A; Wynn R; Coussons M; Meyts I; Boelens JJ
• Successful Engraftment of Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord (R) (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and an Unmanipulated UCB Unit after Myeloablative Chemotherapy in Severe Sickle Cell Disease
  Volume: 23 Page(s): S150 - S151
  03/01/2017 Authors: Parikh S; Brochstein J; Martin PL; Horwitz ME; Galamidi E; Peleg I; Goshen U; Schwarzbach A; Snyder D; Peled T
• Outcomes of Second Transplants for Patients with Hematological Malignancies Who Relapse after First Transplant: A Retrospective Analysis of a Single Institution Experience
  Volume: 23 Page(s): S152 - S152
  03/01/2017 Authors: Stafford L; Troy JD; Driscoll TA; Page K; Parikh S; Prasad VK; Kurtzberg J; Martin PL
• Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord (R) (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease
  Volume: 128
  12/02/2016 Authors: Parikh SH; Brochstein J; Martin PL; Horwitz ME; Galamidi E; Peleg I; Goshen U; Schwarzbach A; Snyder DA; Peled T
• Long-Term Functional Outcomes Following Hematopoietic Stem Cell Transplantation for Early Infantile Krabbe Disease
  Volume: 56 Page(s): 7A - 8A
  06/01/2016 Authors: Allewelt H; Taskindoust M; Troy J; Page K; Wood S; Parikh S; Prasad V; Kurtzberg J
• LONG-TERM FUNCTIONAL OUTCOMES FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR INFANTILE KRABBE DISEASE
  Volume: 63 Page(s): S97 - S97
  06/01/2016 Authors: Allewelt HB; Page K; Taskindoust M; Troy JD; Wood S; Parikh S; Prasad V; Kurtzberg J
• Unrelated Donor Marrow (BMT) or Cord Blood Transplantation (UCBT) for Thalassemia Major after Reduced Intensity Conditioning (URTH Trial Extension)
  Volume: 22 Page(s): S356 - S356
  03/01/2016 Authors: Shenoy S; Ngwube A; Walters MC; Abraham A; Chaudhury S; Soni S; Pulsipher MA; Chan KW; Nieder ML; Parikh S
• A Multicenter Retrospective Analysis Stressing Importance of Tracking Long Term Outcomes Following Hematopoietic Cell Transplantation (HCT) for a-Thalassemia Major
  Volume: 22 Page(s): S29 - S29
  03/01/2016 Authors: Chaudhury S; Ayas M; Rosen C; Ma M; Viqarrudin M; Parikh S; Kharbanda S; Chiang K-Y; Bhatia M; Guilcher G
• Umbilical Cord Blood Transplantation for Cartilage Hair Hypoplasia: A Single Center Experience Demonstrates Excellent Outcomes Using Myeloablative Preparative Regimens
  Volume: 22 Page(s): S235 - S235
  03/01/2016 Authors: Allewelt HB; Patel S; Prasad VK; Kurtzberg J; Driscoll TA; Martin PL; Page K; Parikh S
• Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis
  Volume: 22 Page(s): S257 - S257
  03/01/2016 Authors: Patel S; Allewelt HB; Martin PL; Page K; Driscoll TA; Prasad VK; Kurtzberg J; Parikh S
• Long-Term Functional Outcomes following Hematopoietic Stem Cell Transplantation for Krabbe Disease
  Volume: 22 Page(s): S102 - S103
  03/01/2016 Authors: Allewelt HB; Page K; Taskindoust M; Troy JD; Wood S; Parikh S; Prasad VK; Kurtzberg J
• Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
  Pediatr Blood Cancer Volume: 62 Page(s): 2216 - 2222
  12/01/2015 Authors: Allewelt H; Martin PL; Szabolcs P; Chao N; Buckley R; Parikh S
• Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation.
  Pediatr Transplant Volume: 19 Page(s): 753 - 757
  11/01/2015 Authors: Mahadeo KM; Tewari P; Parikh SH; Driscoll TA; Page K; Martin PL; Kurtzberg J; Prasad VK
• Congenital hemophagocytic lymphohistiocytosis presenting as thrombocytopenia in a newborn.
  J Pediatr Hematol Oncol Volume: 37 Page(s): 300 - 303
  05/01/2015 Authors: Hinson A; Owen W; Prose N; Parikh S; Thornburg C
• Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
  Volume: 21 Page(s): S289 - S291
  02/01/2015 Authors: Heimall J; Logan BR; Cowan MJ; Notarangelo LD; Griffith LM; Puck J; Parikh S; O'Reilly RJ; Pai S-Y; Hanson IC
• Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure of Autologous Recovery Following the First UCBT
  Volume: 21 Page(s): S37 - S38
  02/01/2015 Authors: McFarren A; Smith PB; Page K; Allewelt HB; Parikh S; Driscoll TA; Martin PL; Kurtzberg J; Prasad VK
• Dna Ligase IV Deficiency With Novel Compound Heterozygous Mutations
  Volume: 34 Page(s): 391 - 391
  04/01/2014 Authors: Caldwell JW; Mousallem TI; Dixon N; Buckley RH; Parikh SH
• A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.
  Biol Blood Marrow Transplant Volume: 20 Page(s): 326 - 336
  03/01/2014 Authors: Parikh SH; Mendizabal A; Benjamin CL; Komanduri KV; Antony J; Petrovic A; Hale G; Driscoll TA; Martin PL; Page KM
• Unrelated Umbilical Cord Blood Transplant for Diamond-Blackfan Anemia
  Volume: 20 Page(s): S177 - S177
  02/01/2014 Authors: McFarren A; Page K; Parikh S; Martin PL; Driscoll TA; Kurtzberg J; Prasad VK
• Interplay of Recipient-Donor Matching for HLA, Race/Ethnicity and Gender on Long Term Outcomes in 365 Pediatric Recipients of Single 4/6 Matched Unrelated Cord Blood Transplantation (UCBT) after Myeloablative Therapy
  Volume: 20 Page(s): S87 - S88
  02/01/2014 Authors: Prasad VK; Mendizabal A; Page K; Parikh S; Wishnew J; Driscoll TA; Martin PL; Kurtzberg J
• Results of Cord Blood Transplantation in Children with Nonmalignant Hematologic Conditions
  Page(s): 85 - 106
  01/01/2014 Authors: Page KM; Parikh S; Kurtzberg J
• Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major A er a Reduced Intensity Conditioning Regimen (URTH Trial)
  Volume: 122
  11/15/2013 Authors: Shenoy S; Murray L; Walters MC; Chaudhury S; Soni S; Pulsipher MA; Schultz KR; Chan K; Nieder M; Loechelt B
• Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.
  Bone Marrow Transplant Volume: 48 Page(s): 926 - 931
  07/01/2013 Authors: Kanda J; Kaynar L; Kanda Y; Prasad VK; Parikh SH; Lan L; Shen T; Rizzieri DA; Long GD; Sullivan KM
• Diagnosis of 22q11.2 deletion syndrome and artemis deficiency in two children with T-B-NK+ immunodeficiency.
  J Clin Immunol Volume: 32 Page(s): 1141 - 1144
  10/01/2012 Authors: Heimall J; Keller M; Saltzman R; Bunin N; McDonald-McGinn D; Zakai E; de Villartay J-P; Moshous D; Ariue B; McCarthy EA
• Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.
  Biol Blood Marrow Transplant Volume: 18 Page(s): 1368 - 1377
  09/01/2012 Authors: Tewari P; Martin PL; Mendizabal A; Parikh SH; Page KM; Driscoll TA; Malech HL; Kurtzberg J; Prasad VK
• Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
  Biol Blood Marrow Transplant Volume: 18 Page(s): 1265 - 1272
  08/01/2012 Authors: Kamani NR; Walters MC; Carter S; Aquino V; Brochstein JA; Chaudhury S; Eapen M; Freed BM; Grimley M; Levine JE
• USE OF CYCLOSPORINE IS ASSOCIATED WITH THE INCREASE IN PRE-ENGRAFTMENT SYNDROME AFTER MYELOABLATIVE DUAL CORD BLOOD TRANSPLANTATION
  Volume: 18 Page(s): S332 - S332
  02/01/2012 Authors: Kanda J; Kaynar L; Kanda Y; Prasad VK; Parikh SH; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP
• INCIDENCE OF ADRENAL INSUFFICIENCY IN CHILDREN WITH SANFILIPPO SYNDROME TYPE A FOLLOWING UUCB TRANSPLANT - A RETROSPECTIVE STUDY
  Volume: 18 Page(s): S396 - S396
  02/01/2012 Authors: Moffet J; Parikh S; Driscoll T; Szabolcs P; Kurtzberg J
• UNRELATED DONOR CORD BLOOD TRANSPLANTATION FOR CHILDREN WITH SEVERE SICKLE CELL DISEASE: RESULTS OF A PHASE II STUDY FROM THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK
  Volume: 18 Page(s): S326 - S326
  02/01/2012 Authors: Kamani NR; Walters M; Carter S; Brochstein JA; Eapen M; Levine JE; Logan B; Panepinto J; Parikh S; Pulsipher M
• Reduced-intensity conditioning (RIC) in children with nonmalignant disorders (NMD) undergoing unrelated donor umbilical cord blood transplantation (UCBT).
  Biol Blood Marrow Transplant Volume: 18 Page(s): S53 - S55
  01/01/2012 Authors: Parikh S; Szabolcs P
• Allogeneic transplantation for patients with high-risk or refractory neuroblastoma.
  Volume: 29
  05/20/2011 Authors: Driscoll TA; Martin PL; Moffet J; Daniel M; Page K; Parikh S; Prasad V; Szabolcs P; Kurtzberg J
• DIFFERENTIAL IMPACT OF HLA-A, -B, AND-DRB1 MISMATCHING IN RELATION TO OTHER VARIABLES ON THE OUTCOMES OF MYELOABLATIVE UNRELATED SINGLE DONOR UMBILICAL CORD BLOOD TRANSPLANTATION FROM 4/6 MATCHED UNITS IN CHILDREN AND YOUNG ADULTS
  Volume: 17 Page(s): S185 - S186
  02/01/2011 Authors: Prasad VK; Mendizabal A; Tewari P; Page K; Parikh SH; Szabolcs P; Driscoll TA; Martin PL; Kurtzberg J
• TIME SENSITIVE PARAMETERS OF IMMUNE RECONSTITUTION MEASURED BETWEEN DAY 100 AND 1 YEAR PREDICT SURVIVAL AFTER UNRELATED CORD BLOOD TRANSPLANT (UCBT): THE DYNAMIC IMPACT OF DENDRITIC CELLS, TREGS, AND THYMIC RECOVERY
  Volume: 17 Page(s): S229 - S229
  02/01/2011 Authors: Szabolcs P; Mendizabal AM; Wilfret DA; Reese M; Vinesette R; Page KM; Parikh SH; Kurtzberg J
• EDUCATING PEDIATRIC OUTPATIENT NURSES TO THE UNIQUE CHALLENGES OF REDUCED INTENSITY TRANSPLANT CONDITIONING (RIC) REGIMEN IN CHILDREN WITH NON-MALIGNANT DISORDERS
  Volume: 17 Page(s): S370 - S370
  02/01/2011 Authors: Hollowell RM; Cash J; Stokhuyzen AR; Szabolcs P; Kurtzberg J; Parikh SH
• DURABLE ENGRAFTMENT AND CORRECTION OF GENETIC DEFECT IN CHILDREN WITH CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA FOLLOWING MYELOABLATIVE UMBILICAL CORD BLOOD TRANSPLANTATION
  Volume: 17 Page(s): S256 - S256
  02/01/2011 Authors: Mahadeo KM; Parikh SH; Driscoll TA; Page K; Szabolcs P; Martin PL; Kurtzberg J; Prasad VK
• A PROSPECTIVE STUDY OF REDUCED INTENSITY CONDITIONING (RIC) IN CHILDREN UNDERGOING UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION (UCBT) FOR NON-MALIGNANT DISEASES: PRELIMINARY RESULTS DEMONSTRATE A HIGH RATE OF ENGRAFTMENT AND LOW INCIDENCE OF GVHD
  Volume: 17 Page(s): S265 - S266
  02/01/2011 Authors: Parikh SH; Martin PL; Driscoll TA; Baker J; Piersol K; Moffet J; Stokhuyzen A; Cash J; Kurtzberg J; Szabolcs P
• Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd.
  Volume: 116 Page(s): 1453 - 1454
  11/19/2010 Authors: Parikh SH; Martin PL; Driscoll TA; Baker J; Piersol K; Moffet J; Stokhuyzen A; Kurtzberg J; Szabolcs P
• Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with acute leukemia.
  Pediatr Clin North Am Volume: 57 Page(s): 27 - 46
  02/01/2010 Authors: Peters C; Cornish JM; Parikh SH; Kurtzberg J
• OUTCOMES OF MATCHED RELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH MYELODYSPLASTIC SYNDROME
  Volume: 16 Page(s): S248 - S249
  02/01/2010 Authors: Parikh SH; Martin PL; Prasad VK; Szabolcs P; Ciocci G; Driscoll TA; Kurtzberg J
• CORRECTION OF IMMUNE DEFECT, EXCELLENT SURVIVAL, AND LONG-TERM DONOR CHIMERISM IN CHILDREN WITH CHRONIC GRANULOMATOUS DISEASE AFTER MYELOABLATIVE TRANSPLANTATION ACROSS DONOR AND GRAFT SOURCES
  Volume: 16 Page(s): S185 - S185
  02/01/2010 Authors: Tewari P; Martin PL; Parikh SH; Szabolcs P; Page KM; Driscoll TA; Kurtzberg J; Prasad VK
• Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources
  Volume: 114 Page(s): 1319 - 1319
  11/20/2009 Authors: Tewari P; Wood S; Martin PL; Parikh SH; Szabolcs P; Page KM; Driscoll T; Kurtzberg J; Prasad VK
• Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience.
  Biol Blood Marrow Transplant Volume: 15 Page(s): 948 - 955
  08/01/2009 Authors: Parikh SH; Mendizabal A; Martin PL; Prasad VK; Szabolcs P; Driscoll TA; Kurtzberg J
• Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
  Biol Blood Marrow Transplant Volume: 15 Page(s): 618 - 625
  05/01/2009 Authors: Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P
• OUTCOMES OF UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC PATIENTS WITH PRIMARY AND SECONDARY MYELODYSPLASTIC SYNDROMES
  Volume: 15 Page(s): 72 - 72
  02/01/2009 Authors: Parikh SH; Mendizabal A; Betz-Stablein B; Martin PL; Szabolcs P; Prasad VK; Driscoll TA; Kurtzberg J
• PERICARDIAL EFFUSION FOLLOWING UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION: ANALYSIS IN A COHORT OF 423 PEDIATRIC PATIENTS TRANSPLANTED AT A SINGLE CENTER
  Volume: 15 Page(s): 73 - 74
  02/01/2009 Authors: Hwang EI; Camitta MGW; Vinesett R; Mendizabal A; Wood S; Semmel D; Page K; Driscoll TA; Parikh SH; Szabolcs P
• UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION FROM A SINGLE 4/6 MATCHED UNIT IS AN EFFECTIVE THERAPY FOR CHILDREN WITH MALIGNANT AND NON-MALIGNANT DIAGNOSES: GOOD SURVIVAL, LOW GRAFT FAILURE AND GRAFT-VS-HOST DISEASE IN A SINGLE CENTER ANALYSIS OF 314 PATIENTS
  Volume: 15 Page(s): 27 - 27
  02/01/2009 Authors: Prasad VK; Mendizabal A; Gill P; Parikh SH; Szabolcs P; Driscoll TA; Page K; Wood S; Semmel D; Martin PL
• UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION IS AN EFFECTIVE THERAPY FOR WISKOTT-ALDRICH SYNDROME
  Volume: 15 Page(s): 76 - 76
  02/01/2009 Authors: Sun JM; Driscoll T; Prasad K; Parikh S; Szabolcs P; Kurtzberg Y; Martin PL
• Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients
  Volume: 112 Page(s): 690 - 690
  11/16/2008 Authors: Prasad VK; Gill P; Vinesett R; Parikh SH; Szabolcs P; Driscoll TA; Page KM; Wood S; Semmel D; Martin PL
• Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.
  Blood Volume: 112 Page(s): 2979 - 2989
  10/01/2008 Authors: Prasad VK; Mendizabal A; Parikh SH; Szabolcs P; Driscoll TA; Page K; Lakshminarayanan S; Allison J; Wood S; Semmel D
• Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.
  Biol Blood Marrow Transplant Volume: 14 Page(s): 1108 - 1117
  10/01/2008 Authors: Page KM; Mendizabal AM; Prasad VK; Martin PL; Parikh S; Wood S; Sempowski GD; Szabolcs P; Kurtzberg J
• Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.
  Blood Volume: 112 Page(s): 1005 - 1012
  08/15/2008 Authors: Porkka K; Koskenvesa P; Lundn T; Rimpilinen J; Mustjoki S; Smykla R; Wild R; Luo R; Arnan M; Brethon B
• Risk factor analysis of outcomes after unrelated cord blood transplantation for children with Hurler's Syndrome. A Eurocord-Duke University collaborative study
  Volume: 41 Page(s): S27 - S27
  03/01/2008 Authors: Boelens J; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Ionescu I; Parikh S; Prasad V; Cavazzana-Calvo M; Escolar M
• OUTCOMES OF UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC PATIENTS WITH MYELODYSPLASTIC SYNDROME
  Volume: 14 Page(s): 83 - 84
  02/01/2008 Authors: Parikh SH; Mendizabal A; Martin PL; Szabolcs P; Prasad VK; Driscoll TA; Kurtzberg J
• OUTCOMES OF UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION IN 159 YOUNG PATIENTS WITH PEROXISOMAL AND LYSOSOMAL STORAGE DISORDERS AT A SINGLE CENTER
  Volume: 14 Page(s): 26 - 26
  02/01/2008 Authors: Prasad VK; Mendizabal A; Parikh SH; Szabolcs P; Driscoll T; Page K; Lakshbinarayanan S; Allison J; Wood S; Semmel D
• THE USE, SAFETY, AND EFFICACY OF DACLIZUMAB FOR STEROID REFRACTORY GRAFT-VERSUS-HOST-DISEASE (GVHD) AFTER UNRELATED CORD BLOOD TRANSPLANTATION (UCBT)
  Volume: 14 Page(s): 77 - 77
  02/01/2008 Authors: Mohamed A; Niedzwiecki D; Baker JH; Vinesett R; Martin PL; Driscoll TA; Prasad VK; Parikh S; Kurtzberg J; Szabolcs P
• RISK FACTOR ANALYSIS OF OUTCOMES AFTER UNRELATED CORD BLOOD TRANSPLANTATION FOR CHILDREN WITH HURLERS SYNDROME. AN EUROCORD-DUKE UNIVERSITY COLLABORATIVE STUDY
  Volume: 14 Page(s): 24 - 24
  02/01/2008 Authors: Boelens JJ; Rocha V; Aldenhoven M; Wynn R; Ionescu I; Parikh S; Prasad V; Escolar M; Cacazzana-Calvo M; Gluckman E
• Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation.
  Pediatr Blood Cancer Volume: 49 Page(s): 982 - 984
  12/01/2007 Authors: Parikh SH; Szabolcs P; Prasad VK; Lakshminarayanan S; Martin PL; Driscoll TA; Kurtzberg J
• Analysis of the cellular components of the graft and clinical characteristics of 159 children with lysosomal and peroxisomal disorders (LSD) undergoing unrelated umbilical cord blood transplantation at a single center
  Volume: 110 Page(s): 106A - 106A
  11/16/2007 Authors: Prasad VK; Medizabal A; Parikh SH; Szaboles P; Driscoll TA; Page K; Lakshminarayan S; Allison J; Wood S; Semmell D
• Risk factor analysis of outcomes after unrelated cord blood transplantation for children with Hurler's syndrome. An Eurocord-Duke University Collaborative Study
  Volume: 110 Page(s): 350B - 350B
  11/16/2007 Authors: Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Cavazzana-Calvo M; Ionescu I; Parikh S; Prasad V; Escolar M
• Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
  Biol Blood Marrow Transplant Volume: 13 Page(s): 665 - 674
  06/01/2007 Authors: Beam D; Poe MD; Provenzale JM; Szabolcs P; Martin PL; Prasad V; Parikh S; Driscoll T; Mukundan S; Kurtzberg J
• Dasatinib is an effective treatment of central nervous system Ph-positive leukemia
  Volume: 92 Page(s): 113 - 114
  06/01/2007 Authors: Koskenvesa P; Rimpilainen J; Lundan T; Mustjoki S; Brethon B; Hjorth-Hansen H; Hoglund M; Knutsen H; Parikh S; Raffoux E
• Outcomes of unrelated umbilical cord blood transplantation in pediatric patients with myelodysplastic syndrome
  Volume: 13 Page(s): 64 - 65
  02/01/2007 Authors: Parikh SH; Mendizabal A; Martin PL; Szaboles P; Prasad VK; Driscoll TA; Kurtzberg J
• Outcomes of matched related donor bone marrow transplantation in pediatric patients with myelodysplastic syndrome
  Volume: 13 Page(s): 64 - 64
  02/01/2007 Authors: Parikh SH; Martin PL; Prasad VK; Szaboles P; Driscoll TA; Kurtzbeig J
• Outcomes of pediatric patients transplanted a second time after experiencing graft failure with unrelated donor umbilical cord blood transplantation
  Volume: 13 Page(s): 137 - 137
  02/01/2007 Authors: Baker JH; Martin PL; Driscoll T; Szabolcs P; Allison J; Gurganus K; Ciocci G; Parikh S; Prasad V; Kurtzberg J
• Chronic graft-versus host disease (GVHD) in children with mucopolysacharidoses (MPS) two years after unrelated donor umbilical cord blood transplantation (UCBT)
  Volume: 13 Page(s): 67 - 67
  02/01/2007 Authors: Szaboles P; Martin RL; Parikh S; Prasad VK; Vinesett R; Escolar ML; Kurtzberg J
• The addition of fludarabine to a conventional Busulfan/Melphalan/Anti-Thymocyte globulin (Flu/Bu/Mel/ATG) preparative regimen increased engraftment without additional toxicity.
  Volume: 108 Page(s): 833A - 834A
  11/16/2006 Authors: Lakshminarayanan S; Mendizabal A; Prasad V; Parikh S; Szabolcs P; Driscoll T; Schweitzer M; Kassmann B; Paden M; Robinette D
• Melphalan containing cytoreduction results in a good overall survival (OS) in pediatric patients with relapse or refractory AML undergoing unrelated umbilical cord blood transplantation (UCBT).
  Volume: 108 Page(s): 899A - 899A
  11/16/2006 Authors: Prasad VK; Wu J; Martin PL; Driscoll TA; Parikh SH; Semmel D; Moffet J; Stafford L; Shonkwiler A; Carter S
• Acute graft versus host disease (GVHD) is increased in patients receiving cyclosporine/celicept as frontline prophylaxis against GVKD in pediatric patients undergoing allogeneic stem cell transplantation.
  Volume: 108 Page(s): 820A - 820A
  11/16/2006 Authors: Lakshminarayanan S; Szabolcs P; Prasad V; Parikh S; Wood S; Ciocci G; Stafford L; Boyd L; Driscoll T; Martin PL
• Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling bmt
  Volume: 12 Page(s): 127 - 127
  02/01/2006 Authors: Martin PL; Driscoll TA; Szabolcs P; Parikh SH; Prasad VK; Kurtzberg J
• Single center experience of unrelated umbilical cord blood transplantation (UCBDT) for acute myeloid leukemia (AML) in 97 pediatric patients: Impact of disease status and cytoreductive regimen
  Volume: 12 Page(s): 124 - 124
  02/01/2006 Authors: Prasad VK; Wu J; Parikh SH; Driscoll TA; Szabolcs P; Martin PL; Carter S; Kurtzberg J
• Cellcept/cyclosporine as prophylaxis against graft- versus-host disease in pediatric patients undergoing allogeneic stem cell transplantation
  Volume: 12 Page(s): 67 - 68
  02/01/2006 Authors: Lakshminarayanan S; Martin PL; Szabolcs P; Driscoll T; Parikh S; Prasad V; Kurtzberg J
• Transplant outcomes and stabilization of neurological function in young children with MPS III (Sanfilippo syndrome) after unrelated donor umbilical cord blood transplantation.
  Volume: 106 Page(s): 580A - 580A
  11/16/2005 Authors: Lakshminarayanan S; Szabolcs P; Prasad VK; Parikh S; Allison J; Wood SJ; Escolar M; Kurtzberg J
• Unique reversible but serious adverse events in very young infants undergoing unrelated donor umbilical cord blood transplantation for non-malignant conditions: Increased autoimmune cytopenias and hypertrophic cardiomyopathy.
  Volume: 106 Page(s): 451B - 451B
  11/16/2005 Authors: Lakshminarayanan S; Szabolcs P; Parikh S; Wood SJ; Allison J; Kurtzberg J
• Outcomes of unrelated umbilical cord blood transplantation in pediatric patients with myelodysplastic syndrome
  Volume: 11 Page(s): 80 - 80
  02/01/2005 Authors: Parikh SH; Martin PL; Szabolcs P; Ann S; Prasad V; Driscoll T; Kurtzberg J
• Treatment of pediatric patients with Sanfilippo syndrome (MPS IIIA and IIIB) with unrelated umbilical cord blood transplantation
  Volume: 11 Page(s): 83 - 84
  02/01/2005 Authors: Kurtzberg J; Szabolcs P; Wood S; Ciocci G; Driscoll T; Prasad V; Parikh S; Martin PL; Allison J; Escolar ML
• Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.
  Clin Cancer Res Volume: 10 Page(s): 1150 - 1159
  02/01/2004 Authors: Li X-N; Parikh S; Shu Q; Jung H-L; Chow C-W; Perlaky L; Leung H-CE; Su J; Blaney S; Lau CC
• Transplantation of boys with X-linked adrenoleukodystrophy with unrelated-donor, partially HLA-mismatched banked umbilical cord blood
  Volume: 10 Page(s): 74 - 74
  02/01/2004 Authors: Allison J; Martin PL; Szabolcs P; Driscoll T; Parikh S; Wood S; Kurtzberg J
• Clear cell sarcoma of the kidney: an unusual presentation and review of the literature.
  J Pediatr Hematol Oncol Volume: 20 Page(s): 165 - 168
  01/01/1998 Authors: Parikh SH; Chintagumpala M; Hicks MJ; Trautwein LM; Blaney S; Minifee P; Woo SY
• Polymorphonuclear leukocyte functions in children with cyanotic and acyanotic congenital heart disease.
  Indian Pediatr Volume: 30 Page(s): 883 - 890
  07/01/1993 Authors: Parikh S; Bharucha B; Kamdar S; Kshirsagar N